Rebecca J. Troisi

Staff Scientist
EPIDEMIOLOGY AND BIOSTATISTICS PROGRAM
National Cancer Institute
United States of America

Scientist Medical Sciences
Biography

Dr. Troisi received a Sc.D. from the Harvard School of Public Health in 1994 and joined NCI the same year. Her research has focused on the hormonal etiologies of reproductive cancers and the role of maternal, gestational, neonatal and early life factors in breast cancer risk, including endocrine disruptors such as diethylstilbestrol, a drug previously given to pregnant women. Dr. Troisi and colleagues Dr. Marlene Goldman and Dr. Kathryn Rexrode edited the second edition of Women and Health, a comprehensive review of the behavioral, social, and biological determinants of health and well-being in women, published in late 2012 by Elsevier. She received NIH Merit Awards in 2011 and 2012.

Research Intrest

Hormonal etiologies of reproductive cancers; The role of maternal, gestational, neonatal and early life factors in breast cancer risk, including endocrine disruptors such as diethylstilbestrol (DES); The biology of early life risk factors and implications for cancer risk

List of Publications
Houghton LC, Ganmaa D, Rosenberg PS, Davaalkham D, Stanczyk FZ, Hoover RN, Troisi R. Associations of Breast Cancer Risk Factors with Premenopausal Sex Hormones in Women with Very Low Breast Cancer Risk. International journal of environmental research and public health. 2016 Oct 31;13(11):1066.
Troisi R, Hatch EE, Titus L. The Diethylstilbestrol Legacy: A Powerful Case Against Intervention in Uncomplicated Pregnancy. Pediatrics. 2016 Nov 1;138(Supplement 1):S42-4.
Bjørge T, Gissler M, Ording AG, Engeland A, Glimelius I, Leinonen M, Sørensen HT, Tretli S, Ekbom A, Troisi R, Grotmol T. Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case–control study. British journal of cancer. 2016 Nov 22;115(11):1416.

Global Scientific Words in Medical Sciences